Multiple Myeloma, Breast Cancer, Huntington Disease, Infection, Cancer, Hematologic Cancer, Thrombocytopenia, Hypophosphatemia, Neutropenia. Dr. Rosko’s research aims are to develop an expertise in cancer and aging, advance translational geriatric research efforts, and improve outcomes in older adults with myeloma. Nationally, I am involved with the Cancer and Aging Research Group and have approved in an international investigation of the impact of age and transplant outcomes in ALL patients (EBMT/CIBMTR). Her most recent research proposal focuses on comprehensive frailty assessments paired with biomarkers to predict morbidity and mortality in myeloma patients. Becoming in active member of the OSUCCC will hone leadership skills and will serve as a standard for my professional growth and development. -Multiple myeloma in older adults, cancer and aging

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811